Aereus Technologies Ltd. is a Canadian manufacturing company specializing in antimicrobial copper solutions. Founded in 2009 and headquartered in Guelph, Ontario, the company has developed a proprietary process to create a thin, solid copper alloy layer that kills harmful bacteria on contact and can be applied to almost any solid surface. Aereus' EPA- and PMRA-registered antimicrobial copper solution offers a cost-effective intervention against common hospital pathogens and is suitable for high touch surfaces in various sectors, including medical devices, public transportation, and public buildings. This innovative technology addresses the critical need for effective antimicrobial solutions, particularly in healthcare and public hygiene. Given the increasing emphasis on sanitization and infection control, Aereus Technologies' offering has garnered significant attention within the biotechnology, healthcare, and manufacturing industries. With the potential to revolutionize the approach to surface disinfection, Aereus presents an intriguing opportunity for investors seeking to capitalize on the growing demand for advanced antimicrobial technologies. While specific investment details are not currently available, Aereus Technologies' unique value proposition and its potential to address pressing public health concerns position it as a compelling prospect for venture capital funding.
There is no investment information
No recent news or press coverage available for Aereus Technologies Ltd..